Home » Health » New Vaccination Recommendations for Flu and COVID-19 2023-2024 Season: Target Populations, Available Vaccines, and Incidence Increase

New Vaccination Recommendations for Flu and COVID-19 2023-2024 Season: Target Populations, Available Vaccines, and Incidence Increase

Recently, the Public Health Commission has published the new vaccination recommendations against flu and COVID-19 for the 2023-2024 season. Regarding the target population groups for seasonal vaccination against influenza and COVID-19, the same target populations as in the last update remain: people aged 60 or over; people aged 5 years or older in disability centers and nursing homes, as well as people institutionalized for long periods of time; residents of closed institutions; people under 60 years of age who fall into risk groups; pregnant women and people living with those who have a high degree of immunosuppression. In addition, they include the novelty of the inclusion of “health establishment” personnel, such as those who work in pharmacies.

If we focus only on COVID vaccines, in Spain, as of the date of publication of this document, there are availability of the following vaccines: Original Comirnaty/Ómicron BA. 4-5; Original Spikevax/Omicron BA.1; Spikevax original/ omicron BA. 4-5 and Bimermax. The latter, HIPRA’s recombinant protein dose, was authorized in April 2023 for use as a booster dose in people aged 16 and over who had previously received an mRNA vaccine against COVID-19.

It is a protein S vaccine of the alpha and beta variants of SARS-CoV-2 with SQBA adjuvant as published by the EMA. On the other hand, with this new update has included its neutralization capacity for BA.1 XBB.1.5 strains. without scientific justification to support it in the statement issued by the Public Health Commission. Not in vain, progress was made previously at GM what protection against the new XBB subvariants were not going to be available for the 2023-2024 vaccination seasonIn fact, it was expected for the next campaign.

COVID-19 incidence increase

Furthermore, according to the Commission, in recent weeks a slight increase in the incidence of the disease caused by SARS-CoV-2 has been detected, which is stabilizing. Specifically, the rate is around 130 cases per 100,000 inhabitants in primary care; For its part, three cases per 100,000 inhabitants require hospitalization.

You may also like…

2023-09-20 08:47:30
#Vaccination #recommendations #season

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.